Literature DB >> 21490434

p53-dependent regulation of growth, epithelial-mesenchymal transition and stemness in normal pancreatic epithelial cells.

Andreia V Pinho1, Ilse Rooman, Francisco X Real.   

Abstract

Pancreatic acinar cells acquire in vitro a pancreatic progenitor phenotype associated with activation of p53, growth arrest and senescence. A similar program is also activated in chronic pancreatitis. To assess the mechanisms involved in this process, we cultured pancreatic acinar cells from wild-type, p53(-/-), p16(-/-) and p21(-/-) mice. Cultures from p53(-/-) mice, but not those from p16(-/-) or p21(-/-) mice, display an enhanced proliferation and can be expanded continuously for more than 20 passages. p53(-/-) cells also display features of stemness such as enhanced sphere formation, increased expression of pancreatic multipotent progenitor markers (Ptf1a, Pdx1, Cpa1, c-myc, Sox9 and Hnf1b), and of the stemness regulators Bmi1 and Klf4. Upon subculture, p53(-/-) cells undergo an epithelial-mesenchymal transition (EMT) and express high levels of vimentin and of the transcriptional regulators Snai1, Snai2, Twist, Zeb1 and Zeb2. Genetic lineage tracing unequivocally demonstrates the epithelial origin of the cells with mesenchymal phenotype. These cells express the endodermal markers Hhex, Pdx1, Sox9, Hnf1b, Foxa2, Gata6 and Sox17, and the stem cell markers c-myc, Bmi1 and Klf4. Cultures from p53(+/-) mice display intermediate levels of the transcription factors involved in EMT but do not surpass the growth arrest. Our findings support the notion that p53 controls both growth and epithelial cell differentiation in the pancreas. These observations have important implications regarding the mechanisms through which p53 inactivation in tumors may be associated with aggressive biological behavior.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21490434     DOI: 10.4161/cc.10.8.15363

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  46 in total

Review 1.  From tissue turnover to the cell of origin for pancreatic cancer.

Authors:  Bo Kong; Christoph W Michalski; Mert Erkan; Helmut Friess; Jörg Kleeff
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-07-12       Impact factor: 46.802

2.  Reconstituting pancreas development from purified progenitor cells reveals genes essential for islet differentiation.

Authors:  Takuya Sugiyama; Cecil M Benitez; Amar Ghodasara; Lucy Liu; Graeme W McLean; Jonghyeob Lee; Timothy A Blauwkamp; Roeland Nusse; Christopher V E Wright; Guoqiang Gu; Seung K Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-12       Impact factor: 11.205

3.  Expanding roles of ZEB factors in tumorigenesis and tumor progression.

Authors:  Ester Sánchez-Tilló; Laura Siles; Oriol de Barrios; Miriam Cuatrecasas; Eva C Vaquero; Antoni Castells; Antonio Postigo
Journal:  Am J Cancer Res       Date:  2011-08-20       Impact factor: 6.166

4.  p27(Kip1) enforces maintenance of quiescence in the mammalian ear and the pituitary gland.

Authors:  Martine Roussel
Journal:  Cell Cycle       Date:  2011-08-15       Impact factor: 4.534

5.  p53: Guardian of pancreatic epithelial identity.

Authors:  Bidyut Ghosh; Steven D Leach
Journal:  Cell Cycle       Date:  2011-06-01       Impact factor: 4.534

Review 6.  Krüppel-like factor 4 (KLF4): What we currently know.

Authors:  Amr M Ghaleb; Vincent W Yang
Journal:  Gene       Date:  2017-02-22       Impact factor: 3.688

7.  p53 counteracts reprogramming by inhibiting mesenchymal-to-epithelial transition.

Authors:  R Brosh; Y Assia-Alroy; A Molchadsky; C Bornstein; E Dekel; S Madar; Y Shetzer; N Rivlin; N Goldfinger; R Sarig; V Rotter
Journal:  Cell Death Differ       Date:  2012-09-21       Impact factor: 15.828

8.  Antithetical NFATc1-Sox2 and p53-miR200 signaling networks govern pancreatic cancer cell plasticity.

Authors:  Shiv K Singh; Nai-Ming Chen; Elisabeth Hessmann; Jens Siveke; Marlen Lahmann; Garima Singh; Nadine Voelker; Sophia Vogt; Irene Esposito; Ansgar Schmidt; Cornelia Brendel; Thorsten Stiewe; Jochen Gaedcke; Marco Mernberger; Howard C Crawford; William R Bamlet; Jin-San Zhang; Xiao-Kun Li; Thomas C Smyrk; Daniel D Billadeau; Matthias Hebrok; Albrecht Neesse; Alexander Koenig; Volker Ellenrieder
Journal:  EMBO J       Date:  2015-01-13       Impact factor: 11.598

9.  Lentiviral vector mediated-ASAP1 expression promotes epithelial to mesenchymal transition in ovarian cancer cells.

Authors:  Tao Zhang; Guannan Zhao; Chuanhe Yang; Peixin Dong; Hidemichi Watari; Lin Zeng; Lawrence M Pfeffer; Junming Yue
Journal:  Oncol Lett       Date:  2018-01-22       Impact factor: 2.967

Review 10.  Twist: a molecular target in cancer therapeutics.

Authors:  Md Asaduzzaman Khan; Han-chun Chen; Dianzheng Zhang; Junjiang Fu
Journal:  Tumour Biol       Date:  2013-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.